6:30 AM SIGN-IN & BREAKFAST • 7:00 AM - 8:30 AM
BANDOL 1 (NEW WYNN SPACE)
CE: Primary Immunodeficiency Disorder: Considerations in the Use of Intravenous and Subcutaneous Immunoglobulin
Primary immunodeficiency disease comprises more than 100 variations and affects about 250,000 Americans. This illness is difficult to diagnose and is characterized by susceptibility to infection, ranging in severity from chronic sinusitis to life-threatening sepsis. Recurring infections can severely affect the patient’s ability to attend school, work, and engage in social activities, thereby decreasing quality of life. Current management strategies include stem cell transplantation or treatment with immunoglobulin to improve immune function. It is critical for pharmacists to be aware of the available immunoglobulins available for intravenous and subcutaneous infusion and appreciate the similarities and differences among the various products. Specialty pharmacists are critical in guiding treatment selection, confirming dosing, and providing education and monitoring. This activity will provide practice pearls for specialty pharmacists to improve care for those affected by PID.